What Factors Area Associated With Prognosis After Steroid Hydrodilatation for Adhesive Capsulitis

NCT ID: NCT03622853

Last Updated: 2018-08-09

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-01-01
• Study Completion Date: 2019-03-01

Brief Summary

To investigate the factors associated with improvement after intraarticular steroid injection for patients with Frozen shoulder

Detailed Description

Objective: To investigate the factors associated with improvement after intraarticular steroid injection for patients with Frozen shoulder

Design: Prospective study.

Participants: Patients with Frozen shoulder were recorded the demographic data, associated disease, ultrasound findings at baselines.

Intervention: One shot intraarticular steroid hydrodilatation

Main Outcome Measures: Visual analog scale (VAS) of the shoulder pain, Constant score, SPADI score, and angles of active and passive shoulder range of motion (flexion, abduction, external rotation, and internal rotation) at pre-treatment, post-treatment at week 8

Conditions

Adhesive Capsulitis

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

intraarticular steroid injection

intraarticular steroid hydrodilatation (shincort 40mg )

Group Type: EXPERIMENTAL

Steroid (shincort)

Intervention Type: DRUG

intraarticular shincort 40mg / 4ml mixed with 2% xylocaine and Normal saline

Interventions

Steroid (shincort)

intraarticular shincort 40mg / 4ml mixed with 2% xylocaine and Normal saline

Intervention Type: DRUG

Other Intervention Names

shincort

Eligibility Criteria

Inclusion Criteria

• Diagnosis of frozen shoulder by physical examination and ultrasonography

Exclusion Criteria

1. other conditions involving the shoulder ( rheumatoid arthritis, Hill-Sachs lesions,osteoporosis, or malignancies in the shoulder region);

2. neurologic deficits affecting shoulder function in normal daily activities;

3. shoulder pain caused by cervical radiculopathy

4. a history of drug allergy to xylocaine

5. pregnancy or lactation;

6. received injection into the affected shoulder during the preceding 3 months

• Minimum Eligible Age: 35 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status: RECRUITING

Countries

Taiwan

Central Contacts

Jia chi c Wang, MD

Role: CONTACT

jcwang0726@gmail.com

919527693

Facility Contacts

Jia c Wang

Role: primary

jcwang0726@gmail.com

919527693

Other Identifiers

2017-02-005c

Identifier Type: -

Identifier Source: org_study_id